CardioTACS In Situ Apoptosis Detection Kit 4827-30-K from R&D Systems, a Bio-Techne Brand

Product Specs
ItemCardioTACS In Situ Apoptosis Detection Kit
CompanyR&D Systems, a Bio-Techne Brand
Price Pricing Info Supplier Page View Company Product Page
Catalog Number4827-30-K
Quantity30 Tests
Brand/TrademarkR&D Systems, a Bio-Techne Brand
StorageThe product requires storage at -20 to -70 °C, 2 - 8 °C, and room temperature. Consult the product insert for specific storage temperatures. Do not use past expiration date

Specifications/Features

Available conjugates: HRP

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) miR-488-3p Protects Cardiomyocytes against Doxorubicin-Induced Cardiotoxicity by Inhibiting CyclinG1Oxidative medicine and cellular longevityJanuary 1, 2022Yan M, Cao Y, Wang Q, Xu K, Dou L, Huang X, Chen B, Tang W, Lan M, Liu B, et al.previously [16]. 2.8. In Situ Apoptosis Detection The CardioTACS™ In Situ Apoptosis Detection Kit (4827-30-K) was obtained from R&D Systems, Inc. As previously described, the cultured cardiomyocytes or cryosection

(2) Protection against Doxorubicin-Related Cardiotoxicity by Jaceosidin Involves the Sirt1 Signaling PathwayOxidative medicine and cellular longevityJanuary 1, 2021Liu Y, Zhou L, Du B, Liu Y, Xing J, Guo S, Li L, Chen H.

(3) Galectin-3: A Cardiomyocyte Antiapoptotic Mediator at 24-Hour Post Myocardial InfarctionCellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacologyApril 4, 2020Al-Salam S, Hashmi S, Jagadeesh GS, Tariq S.

(4) Reversal of cardiac, vascular, and renal dysfunction by non-quinazoline α1-adrenolytics in DOCA-salt hypertensive rats: a comparison with prazosin, a quinazoline-based α1-adrenoceptor antagonistHypertension research : official journal of the Japanese Society of HypertensionAugust 1, 2019Kubacka M, Zadrożna M, Nowak B, Kotańska M, Filipek B, Waszkielewicz AM, Marona H, Mogilski S.

(5) Effects of low-dose oxygen ions and protons on cardiac function and structure in male C57BL/6J miceLife sciences in space researchFebruary 1, 2019Seawright JW, Sridharan V, Landes RD, Cao M, Singh P, Koturbash I, Mao XW, Miousse IR, Singh SP, Nelson GA, et al.

(6) REV-ERBα ameliorates heart failure through transcription repressionJCI insightSeptember 7, 2017Zhang L, Zhang R, Tien CL, Chan RE, Sugi K, Fu C, Griffin AC, Shen Y, Burris TP, Liao X, et al.

(7) Phosphodiesterase 5 Inhibition Limits Doxorubicin-induced Heart Failure by Attenuating Protein Kinase G Iα OxidationThe Journal of biological chemistryAugust 12, 2016Prysyazhna O, Burgoyne JR, Scotcher J, Grover S, Kass D, Eaton P.

(8) IGF-1 degradation by mouse mast cell protease 4 promotes cell death and adverse cardiac remodeling days after a myocardial infarctionProceedings of the National Academy of Sciences of the United States of AmericaJune 21, 2016Tejada T, Tan L, Torres RA, Calvert JW, Lambert JP, Zaidi M, Husain M, Berce MD, Naib H, Pejler G, et al.

(9) GSK-3β heterozygous knockout is cardioprotective in a knockin mouse model of familial dilated cardiomyopathyAmerican journal of physiology. Heart and circulatory physiologyJune 1, 2016Mohamed RM, Morimoto S, Ibrahim IA, Zhan DY, Du CK, Arioka M, Yoshihara T, Takahashi-Yanaga F, Sasaguri T.

(10) The influence of age on serum concentrations of cardiac troponin I: results in rats, monkeys, and commercial seraToxicologic pathologyJuly 1, 2014Herman EH, Knapton A, Liu Y, Lipshultz SE, Estis J, Todd J, Woodward RA, Cochran T, Zhang J, Poirier MC.

(11) Silencing of p53 RNA through transarterial delivery ameliorates renal tubular injury and downregulates GSK-3β expression after ischemia-reperfusion injuryAmerican journal of physiology. Renal physiologyDecember 1, 2013Fujino T, Muhib S, Sato N, Hasebe N.

(12) Probenecid as a noninjurious positive inotrope in an ischemic heart disease murine modelJournal of cardiovascular pharmacology and therapeuticsMay 1, 2013Koch SE, Tranter M, Robbins N, Luther K, Singh U, Jiang M, Ren X, Tee T, Smith L, Varma P, et al.

(13) Pressure overload-induced cardiac remodeling and dysfunction in the absence of interleukin 6 in miceLaboratory investigation; a journal of technical methods and pathologyNovember 1, 2012Lai NC, Gao MH, Tang E, Tang R, Guo T, Dalton ND, Deng A, Tang T.

(14) A multifaceted evaluation of imatinib-induced cardiotoxicity in the ratToxicologic pathologyDecember 1, 2011Herman EH, Knapton A, Rosen E, Thompson K, Rosenzweig B, Estis J, Agee S, Lu QA, Todd JA, Lipshultz S, et al.

(15) Growth differentiation factor 5 regulates cardiac repair after myocardial infarctionJournal of the American College of CardiologyJanuary 12, 2010Zaidi SH, Huang Q, Momen A, Riazi A, Husain M.

(16) Targeted cardiac expression of soluble Fas prevents the development of heart failure in mice with cardiac-specific expression of MCP-1Journal of molecular and cellular cardiologyJune 1, 2006Niu J, Azfer A, Deucher MF, Goldschmidt-Clermont PJ, Kolattukudy PE.

(17) Tumor necrosis factor receptor deficiency exacerbated Adriamycin-induced cardiomyocytes apoptosis: an insight into the Fas connectionMolecular cancer therapeuticsFebruary 1, 2006Lien YC, Lin SM, Nithipongvanitch R, Oberley TD, Noel T, Zhao Q, Daosukho C, St Clair DK.

Be the First to Write a Review!

CardioTACS In Situ Apoptosis Detection Kit

CardioTACS In Situ Apoptosis Detection Kit

CardioTACS In Situ Apoptosis Detection Kit

CardioTACS In Situ Apoptosis Detection Kit from R&D Systems, a Bio-Techne Brand

Specifications/Features

R&D Systems, a Bio-Techne Brand

Citations (17)

Reviews

CardioTACS In Situ Apoptosis Detection Kit from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map